Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AMN vs $NEO | Chartloom

Compare

$AMN vs $NEO

AMN Healthcare Services Inc · Neogenomics Inc

AMN

AMN Healthcare Services Inc

NEO

Neogenomics Inc

Compare $AMN vs $NEO

Comparing AMN Healthcare Services Inc and Neogenomics Inc

AMNAMN Healthcare Services Inc

NEONeogenomics Inc

AMNAMN Healthcare Services Inc

Market cap

$1.46B

P/E (TTM)

14.26x

Forward P/E (NTM)

43.92x

Forward P/S (NTM)

0.55x

Rev growth (TTM)

24.0%

YTD performance

149.1%

52W performance

96.5%

FCF yield

30.0%

NEONeogenomics Inc

Market cap

$2.17B

P/E (TTM)

—

Forward P/E (NTM)

60.23x

Forward P/S (NTM)

2.55x

Rev growth (TTM)

11.2%

YTD performance

43.5%

52W performance

80.7%

FCF yield

-0.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AMN

NEO

Detailed metrics comparison

AMN

AMN Healthcare Services Inc

NEO

Neogenomics Inc

Market Cap

AMN$1.46B

NEO$2.17B

Enterprise Value

AMN$1.84B

NEO$2.40B

Price

AMN$37.66

NEO$16.88

P/E Ratio

AMN14.26x

NEON/A

P/S Ratio

AMN0.43x

NEO2.83x

EV/Sales

AMN0.54x

NEO3.14x

EV/EBITDA

AMN5.99x

NEO508.39x

P/B Ratio

AMN1.91x

NEO2.67x

P/FCF Ratio

AMN3.33x

NEON/A

EV/FCF

AMN4.20x

NEO-326.74x

PEG Ratio

AMNN/A

NEON/A

Forward P/E (NTM)

AMN43.92x

NEO60.23x

Forward P/S (NTM)

AMN0.55x

NEO2.55x

Revenue (TTM)

AMN$3.43B

NEO$766M

Revenue Growth (YoY)

AMN24.0%

NEO11.2%

Forward Rev Growth

AMN-20.5%

NEO10.0%

Gross Margin (TTM)

AMN27.8%

NEO43.9%

Operating Margin (TTM)

AMN5.8%

NEO0.0%

EBITDA Margin (TTM)

AMN8.9%

NEO0.6%

Net Margin (TTM)

AMN3.1%

NEO-6.8%

FCF Margin (TTM)

AMN12.8%

NEO-1.0%

Net Income (TTM)

AMN$105M

NEO$-52M

FCF (TTM)

AMN$439M

NEO$-7M

EPS (TTM)

AMN$2.64

NEO-$0.40

ROE (TTM)

AMN15.3%

NEO-631.0%

ROA (TTM)

AMN4.6%

NEO-382.0%

ROIC (TTM)

AMN7.2%

NEO-442.0%

Cash

AMN$362M

NEO$146M

Debt

AMN$743M

NEO$380M

Net Cash/Debt

AMN$-381M

NEO$-234M

Current Ratio (TTM)

AMN1.13x

NEO3.60x

Quick Ratio (TTM)

AMN1.10x

NEO3.12x

Debt/Equity (TTM)

AMN1.00x

NEO0.48x

Debt/Assets (TTM)

AMN0.0%

NEO0.0%

Interest Coverage (TTM)

AMNN/A

NEON/A

Net Debt/EBITDA (TTM)

AMN0.00x

NEO0.00x

Beta

AMN0.51

NEO1.87

52W Performance

AMN96.5%

NEO80.7%

YTD Performance

AMN149.1%

NEO43.5%

% from 52W High

AMN-2.0%

NEO-16.2%

% from 52W Low

AMN151.6%

NEO138.8%

Asset Turnover (TTM)

AMN1.49x

NEO0.56x

FCF Yield (TTM)

AMN30.0%

NEO-0.3%

Earnings Yield (TTM)

AMN7.2%

NEO-2.4%

Dividend Yield (TTM)

AMNN/A

NEON/A

Rule of 40

AMN36.8

NEO10.2

EV/GP/RG

AMNN/A

NEO0.64

Ticker research

View AMN research View NEO research

Metric	AMN AMN Healthcare Services Inc	NEO Neogenomics Inc
Market & Valuation
Market Cap	$1.46B	$2.17B
Enterprise Value	$1.84B	$2.40B
Price	$37.66	$16.88
P/E Ratio	14.26x	N/A
P/S Ratio	0.43x	2.83x
EV/Sales	0.54x	3.14x
EV/EBITDA	5.99x	508.39x
P/B Ratio	1.91x	2.67x
P/FCF Ratio	3.33x	N/A
EV/FCF	4.20x	-326.74x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	43.92x	60.23x
Forward P/S (NTM)	0.55x	2.55x
Revenue & Growth
Revenue (TTM)	$3.43B	$766M
Revenue Growth (YoY)	24.0%	11.2%
Forward Rev Growth	-20.5%	10.0%
Profitability
Gross Margin (TTM)	27.8%	43.9%
Operating Margin (TTM)	5.8%	0.0%
EBITDA Margin (TTM)	8.9%	0.6%
Net Margin (TTM)	3.1%	-6.8%
FCF Margin (TTM)	12.8%	-1.0%
Net Income (TTM)	$105M	$-52M
FCF (TTM)	$439M	$-7M
EPS (TTM)	$2.64	-$0.40
ROE (TTM)	15.3%	-631.0%
ROA (TTM)	4.6%	-382.0%
ROIC (TTM)	7.2%	-442.0%
Financial Health
Cash	$362M	$146M
Debt	$743M	$380M
Net Cash/Debt	$-381M	$-234M
Current Ratio (TTM)	1.13x	3.60x
Quick Ratio (TTM)	1.10x	3.12x
Debt/Equity (TTM)	1.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.51	1.87
52W Performance	96.5%	80.7%
YTD Performance	149.1%	43.5%
% from 52W High	-2.0%	-16.2%
% from 52W Low	151.6%	138.8%
Efficiency & Yields
Asset Turnover (TTM)	1.49x	0.56x
FCF Yield (TTM)	30.0%	-0.3%
Earnings Yield (TTM)	7.2%	-2.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	36.8	10.2
EV/GP/RG	N/A	0.64
Ticker research	View AMN research	View NEO research

Valuation

P/E Ratio

AMN

14.26x

P/S Ratio

AMN

0.43x

NEO

2.83x

EV/FCF

NEO

-326.74x

AMN

4.20x

Growth & revenue

Revenue Growth TTM

AMN

24.0%

NEO

11.2%

Forward Revenue Growth

NEO

10.0%

AMN

-20.5%

Profitability & performance

Gross Margin

NEO

43.9%

AMN

27.8%

ROE

AMN

15.3%

NEO

-631.0%

FCF Yield %

AMN

30.0%

NEO

-0.3%

52-Week Performance

AMN

96.5%

NEO

80.7%

Detailed metrics comparison

AMN

AMN Healthcare Services Inc

NEO

Neogenomics Inc

Market Cap

AMN$1.46B

NEO$2.17B

Enterprise Value

AMN$1.84B

NEO$2.40B

Price

AMN$37.66

NEO$16.88

P/E Ratio

AMN14.26x

NEON/A

P/S Ratio

AMN0.43x

NEO2.83x

EV/Sales

AMN0.54x

NEO3.14x

EV/EBITDA

AMN5.99x

NEO508.39x

P/B Ratio

AMN1.91x

NEO2.67x

P/FCF Ratio

AMN3.33x

NEON/A

EV/FCF

AMN4.20x

NEO-326.74x

PEG Ratio

AMNN/A

NEON/A

Forward P/E (NTM)

AMN43.92x

NEO60.23x

Forward P/S (NTM)

AMN0.55x

NEO2.55x

Revenue (TTM)

AMN$3.43B

NEO$766M

Revenue Growth (YoY)

AMN24.0%

NEO11.2%

Forward Rev Growth

AMN-20.5%

NEO10.0%

Gross Margin (TTM)

AMN27.8%

NEO43.9%

Operating Margin (TTM)

AMN5.8%

NEO0.0%

EBITDA Margin (TTM)

AMN8.9%

NEO0.6%

Net Margin (TTM)

AMN3.1%

NEO-6.8%

FCF Margin (TTM)

AMN12.8%

NEO-1.0%

Net Income (TTM)

AMN$105M

NEO$-52M

FCF (TTM)

AMN$439M

NEO$-7M

EPS (TTM)

AMN$2.64

NEO-$0.40

ROE (TTM)

AMN15.3%

NEO-631.0%

ROA (TTM)

AMN4.6%

NEO-382.0%

ROIC (TTM)

AMN7.2%

NEO-442.0%

Cash

AMN$362M

NEO$146M

Debt

AMN$743M

NEO$380M

Net Cash/Debt

AMN$-381M

NEO$-234M

Current Ratio (TTM)

AMN1.13x

NEO3.60x

Quick Ratio (TTM)

AMN1.10x

NEO3.12x

Debt/Equity (TTM)

AMN1.00x

NEO0.48x

Debt/Assets (TTM)

AMN0.0%

NEO0.0%

Interest Coverage (TTM)

AMNN/A

NEON/A

Net Debt/EBITDA (TTM)

AMN0.00x

NEO0.00x

Beta

AMN0.51

NEO1.87

52W Performance

AMN96.5%

NEO80.7%

YTD Performance

AMN149.1%

NEO43.5%

% from 52W High

AMN-2.0%

NEO-16.2%

% from 52W Low

AMN151.6%

NEO138.8%

Asset Turnover (TTM)

AMN1.49x

NEO0.56x

FCF Yield (TTM)

AMN30.0%

NEO-0.3%

Earnings Yield (TTM)

AMN7.2%

NEO-2.4%

Dividend Yield (TTM)

AMNN/A

NEON/A

Rule of 40

AMN36.8

NEO10.2

EV/GP/RG

AMNN/A

NEO0.64

Ticker research

View AMN research View NEO research

Metric	AMN AMN Healthcare Services Inc	NEO Neogenomics Inc
Market & Valuation
Market Cap	$1.46B	$2.17B
Enterprise Value	$1.84B	$2.40B
Price	$37.66	$16.88
P/E Ratio	14.26x	N/A
P/S Ratio	0.43x	2.83x
EV/Sales	0.54x	3.14x
EV/EBITDA	5.99x	508.39x
P/B Ratio	1.91x	2.67x
P/FCF Ratio	3.33x	N/A
EV/FCF	4.20x	-326.74x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	43.92x	60.23x
Forward P/S (NTM)	0.55x	2.55x
Revenue & Growth
Revenue (TTM)	$3.43B	$766M
Revenue Growth (YoY)	24.0%	11.2%
Forward Rev Growth	-20.5%	10.0%
Profitability
Gross Margin (TTM)	27.8%	43.9%
Operating Margin (TTM)	5.8%	0.0%
EBITDA Margin (TTM)	8.9%	0.6%
Net Margin (TTM)	3.1%	-6.8%
FCF Margin (TTM)	12.8%	-1.0%
Net Income (TTM)	$105M	$-52M
FCF (TTM)	$439M	$-7M
EPS (TTM)	$2.64	-$0.40
ROE (TTM)	15.3%	-631.0%
ROA (TTM)	4.6%	-382.0%
ROIC (TTM)	7.2%	-442.0%
Financial Health
Cash	$362M	$146M
Debt	$743M	$380M
Net Cash/Debt	$-381M	$-234M
Current Ratio (TTM)	1.13x	3.60x
Quick Ratio (TTM)	1.10x	3.12x
Debt/Equity (TTM)	1.00x	0.48x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.51	1.87
52W Performance	96.5%	80.7%
YTD Performance	149.1%	43.5%
% from 52W High	-2.0%	-16.2%
% from 52W Low	151.6%	138.8%
Efficiency & Yields
Asset Turnover (TTM)	1.49x	0.56x
FCF Yield (TTM)	30.0%	-0.3%
Earnings Yield (TTM)	7.2%	-2.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	36.8	10.2
EV/GP/RG	N/A	0.64
Ticker research	View AMN research	View NEO research